Coherus BioSciences   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Redwood City CA United States (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2014
NCT02115750
First Marketed Drug
2018
filgrastim (neupogen)
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Coherus Biosciences, Inc. | COHERUS BIOSCIENCES INC | Coherus BioSciences (parent company for Zao InteKrin)